AEHR

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Aehr Test Systems (AEHR) kicked off its latest earnings season with Q4 2026 results that drew fresh attention to the stock, as investors weighed a quarterly profit against a weaker full year. See our latest analysis for Aehr Test Systems. The earnings surprise has been reflected in Aehr Test Systems’ share price, with a 1-day share price return of 21.91% and 7-day share price return of 29.31%. However, the 30-day share price return is down 24.24%. Over the past year, total shareholder return is very large compared with a 77.39% total shareholder return over three years, suggesting strong long term momentum that has recently cooled and then picked up again around the results. If the post earnings move in Aehr Test Systems has you looking across the chip supply chain, this is a useful moment to scan for other AI exposed opportunities using the 52 AI infrastructure stocks After a 1 day jump and a large 1 year return, Aehr Test Systems still trades about 23% below the average analyst price target. Is that a gap worth closing, or a warning the market is right to leave open? Aehr Test Systems closed at $87.79, while the most followed narrative on the stock suggests a fair value of $18.27, creating a wide valuation gap for investors to unpack. Read the complete narrative. The narrative focuses on how years of dilution, insider selling and expectations for future earnings shape that $18.27 fair value. Curious which revenue path, profit assumptions and valuation multiple sit under that gap versus today’s $87.79 share price? Result: Fair Value of $18.27 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, if Aehr Test Systems delivers steadier profitability or insider activity shifts toward buying or retention, that could challenge parts of this overvaluation narrative. Find out about the key risks to this Aehr Test Systems narrative. If this Aehr Test Systems story feels finely balanced between concern and optimism, consider acting promptly, reviewing the underlying metrics, and weighing both the 2 key rewards and 2 important warning signs. If Aehr Test Systems has sharpened your focus, you can use this momentum to line up a few more quality candidates before the next round of r...

Semiconductor equipment giant ASML beat estimates for the second quarter and raised its outlook for the full year. ASML stock rose on the news.

Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted earnings of $0.11 per diluted share for the quarter ended May 29, 2026, compared with analyst expectations for a loss of $0.01 per share. Revenue came in at $18.8 million, ahead of consensus estimates of $17.9 million and up from $14.1 million in the year-ago period. On a GAAP basis, Aehr reported net income of $1.4 million, or $0.04 per diluted share, compared with a net loss of $2.9 million, or $0.10 per diluted share, in the fourth quarter of fiscal 2025. Non-GAAP net income, which excludes stock-based compensation and acquisition-related adjustments, was $3.6 million, or $0.11 per diluted share, compared with a non-GAAP loss of $0.2 million, or $0.01 per share, a year earlier. The company also reported record quarterly bookings of $60.7 million, contributing to backlog of $80.6 million as of May 29. Including bookings received after the quarter-end, Aehr’s effective backlog stood at approximately $100.6 million. For the full fiscal year 2026, revenue totaled $50 million, compared with $59 million in fiscal 2025. The company reported a GAAP net loss of $7.1 million, or $0.23 per diluted share, compared with a net loss of $3.9 million, or $0.13 per share, in the prior year. Aehr ended the fiscal year with $116.5 million in cash, cash equivalents and restricted cash, up from $37.1 million at the end of its fiscal third quarter. “We are very pleased with our fiscal fourth quarter performance, which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr,” Aehr CEO Gayn Erickson said in a statement. “Record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics, and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward.” For fiscal 2027, management forecast revenue of between $130 million and $150 million, significantly above analyst expectations of roughly $85 million.

Image source: The Motley Fool. Tuesday, July 14, 2026 at 5:00 p.m. ET President and Chief Executive Officer - Gayn Erickson Chief Financial Officer - Chris Siu Investor Relations - Jim Byers Operator: Good afternoon. Thank you for holding your conference will begin very shortly. Please remain on the line. Your conference will begin in just a couple of minutes. Good day. Welcome to the Aehr Test Systems Fiscal 26 Fourth Quarter and Full Year Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Jim Byers, at Pondel Wilkinson Investor Relations. Jim, you may begin. Jim Byers: Thank you, operator. Good afternoon, and welcome to Aehr Test Systems Fiscal 26 Fourth Quarter and Full Year Financial Results Conference Call. With me on today's call are Aehr Test Systems President and Chief Executive Officer, Gayn Erickson and Chief Financial officer, Chris Siu. Before I turn the call over to Chris and Gayn, I would like to cover a few quick items. This afternoon, right after market close, Aehr Test issued a press release announcing its fiscal 26 fourth quarter and full-year results. That release is available on the company's website at aehr.com. This call is being broadcast live over the Internet. For all interested parties and the webcast will be archived on the Investor Relations page of the company's website. And I would like to remind everyone that on today's call, management will be making forward looking statements. That are based on current information and estimates and are subject to a number of risks and uncertainties, that could cause actual results to differ materially from those in the forward looking statements. These factors are discussed in the company's most recent periodic and current reports filed with the SEC. These forward looking statements, including guidance provided during today's call, are only valid as of this date, and Aehr Test Systems undertakes no obligation to update the forward looking statements. Now with that said, I would like to turn the call over to Gayn Erickson, President and CEO. Gayn Erickson: Thanks, Jim, and good afternoon, everyone, and welcome to our fiscal 2026 fourth quarter and full year earnings conference call. I will start with an updat...

Aehr Test Systems (AEHR) stock pushed higher after the semiconductor equipment manufacturer delivered a remarkable Q4 earnings report on Tuesday evening. The company reported adjusted earnings of $0.11 per share, dramatically surpassing the consensus estimate for a loss of $0.01, while revenue of $18.84 million exceeded the $18.69 million forecast and represented a 34% year-over-year increase from $14.09 million. Nvidia Stock Could Still Soar 140% to Reach $500, Says Wall Street MU Stock Alert: What to Watch as Micron Takes a Stake in GlobalWafers IBM Stock Just Suffered a Gruesome Massacre, But Algos Likely Sense a Huge Discount Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Including the post-earnings rally, AEHR shares are trading at more than 4x their price at the start of this year. The most compelling aspect of the report was not the quarterly beat itself but the extraordinary forward guidance. Management issued fiscal 2027 revenue guidance of $140 million, representing growth of about 180% over last year’s revenue of $50 million and crushing the consensus estimate of roughly $85 million. The company also projected non-GAAP pretax net income margins of 18% to 22% of total revenue for fiscal 2027. Record quarterly bookings of $60.7 million — up more than 500% from $11.1 million in the prior-year quarter — underpinned the bullish outlook. The backlog hit a record $80.6 million as of May 29, and the effective backlog, including bookings received after that date, climbed to $100.6 million. This level of visibility into future revenue provides substantial credibility to what otherwise might appear to be an overly ambitious guidance range. Aehr Test Systems has undergone a dramatic transformation in its revenue mix. Two years ago, over 95% of the company’s business was tied to silicon carbide testing for electric vehicles (EVs), whereas nearly 95% of fiscal 2026 revenue came from markets outside EV silicon carbide. Artificial intelligence (AI) processors, CPUs, and network processors now represent roughly 71% of annual revenue, with silicon photonics and data center infrastructure applications accounting for about 20%. AI and silicon photonics burn-in made up more than 80% of fourth-quarter revenue specifically. Management highlighted that its lead AI wafer-level customer ha...

Aehr Test Systems AEHR reported non-GAAP earnings of 11 cents per share for the fourth quarter of fiscal 2026, surpassing the Zacks Consensus Estimate by 1200%. The company had posted a loss of 1 cent per share in the year-ago quarter.Revenues increased 33.7% year over year to $18.84 million and beat the consensus mark by 0.72%. Higher artificial intelligence (AI) and data-center demand, improved manufacturing utilization and favorable product mix supported profitability. Quarterly bookings reached a record $60.7 million. AI processors and silicon photonics burn-in generated more than 80% of fiscal fourth-quarter revenues, up from 56% in the prior-year period. Demand was particularly strong for FOX systems, serial AutoAligners and proprietary WaferPak contactors.Three customers each accounted for more than 10% of quarterly revenues. Two served the AI market, while the third focused on optical transceivers used in data centers. Contactor revenues totaled $5.8 million, representing 31% of the company’s top line compared with 30% a year earlier. Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote Non-GAAP gross margin expanded to 45% from 35% in the year-ago quarter. The 1,000-basis-point improvement reflected higher revenues, better manufacturing capacity utilization and a more favorable product mix.Non-GAAP operating expenses increased to $7.5 million from $5.4 million. The rise primarily reflected higher employment costs tied to research and development hiring, along with increased commissions associated with strong AI and data center bookings and legal expenses associated with patent litigation in China. Quarterly bookings surged more than 500% year over year to $60.7 million from $11.1 million. Growth was driven by orders for Sonoma package-level systems, FOX wafer-level systems, WaferPaks and burn-in module boards supporting AI and silicon photonics applications.Backlog at fiscal year-end reached $80.6 million, up from $15.2 million a year earlier. AEHR received another $20 million in bookings shortly after year-end, lifting effective backlog to approximately $100.6 million and providing substantial visibility into fiscal 2027 revenues. The lead AI wafer-level burn-in customer doubled its system base during fiscal 2026 and shifted all production burn-in screening from system-level to wafer-level testing. Management expects furth...

Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it was optimistic about growing its revenues by 160 percent to 200 percent to a range of $130 million to $150 million, versus the $50 million last year. For illustration purposes only. Photo from Pixabay/Pexels The guidance was supported by an effective backlog of $100 million, providing investors with greater visibility into future revenues. The aggressive outlook helped investors look beyond the company’s weak earnings performance in the full fiscal year 2026, betting that its backlog and increasing AI exposure could mark the beginning of a new growth cycle. Aehr Test Systems (NASDAQ:AEHR) said that its net loss went 82 percent deeper during the period, ending at $7.1 million versus the $3.9 million last year. Revenues were also lower by 15 percent at $50 million versus $59 million year-on-year. However, the company swung to a net profit of $1.4 million in the fourth quarter of fiscal year 2026 from a net loss of $2.9 million in the same period last year, as revenues surged by 33 percent to $18.8 million from $14.1 million year-on-year. Bookings finished at a record of $60.7 million, while backlogs ended at $80.6 million. Effective backlog, including bookings since May 29, was at $100.6 million. Aehr Test Systems (NASDAQ:AEHR) President and CEO Gayn Erickson said that they were pleased with the results, “which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr.” “[Our] record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics, and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward,” he said. More institutional investors are buying into shares of Aehr Test Systems (NASDAQ:AEHR). Based on Insider Monkey’s database, 25 hedge funds held positions in the company as of the end of the first quarter of the year, up from 17 in the quarter prior. Collectively, those funds own approximately $60.9 million worth of stake in the company, signaling th...

Aehr Test Systems, Inc. AEHR used its fourth-quarter 2026 call to focus less on the quarter itself and more on the scale of demand it sees building into fiscal 2027. Management tied that outlook to AI processors, silicon photonics and a record-effective backlog.The company still posted a headline beat, with adjusted EPS of 11 cents versus the Zacks Consensus Estimate of a loss of 1 cent and revenues of $18.8 million versus the estimate of $18.7 million. But the call’s main takeaway was the visibility management says it now has into a much larger revenue year ahead. Aehr Test Systems price-consensus-eps-surprise-chart | Aehr Test Systems Quote President and CEO Gayn Erickson said the company entered fiscal 2027 with strong momentum, citing record quarterly bookings, record backlog and rising demand across wafer-level and package-level burn-in. He framed those trends as the base for a multiyear growth setup rather than a one-quarter rebound. Management guided fiscal 2027 revenues of $130 million to $150 million, or about 2.6 times to 3 times fiscal 2026 revenues, with non-GAAP pretax profitability of 18% to 22%. CFO Chris Siu said the outlook reflects current backlog and anticipated customer demand. The quarter’s reported numbers helped support that message. Revenues rose 34% year over year, while non-GAAP net income reached $3.6 million versus a loss a year earlier. Erickson said nearly 95% of fiscal 2026 revenues came from markets outside electric-vehicle silicon carbide, a sharp change from two years ago. He identified AI accelerators, CPUs and network processors as the fastest-growing end market, accounting for about 71% of annual revenue. He also said the lead AI wafer-level customer has moved all production burn-in screening to wafer level on Aehr systems and is forecasting higher capacity needs. That customer has doubled its systems and added automated aligners, underscoring how central AI has become to the company’s story. In package-level burn-in, Erickson said the lead hyperscale customer is expanding Sonoma purchases for a second device with twice the power of the first. He added that Sonoma systems and consumables could become a larger revenue contributor as those devices ramp. One of the call’s more important updates came from a benchmark with a major supplier of AI accelerators, CPUs and network processors. Erickson said Aehr completed testing on...

Aehr Test Systems (AEHR) reported fiscal Q4 adjusted earnings late Tuesday of $0.11 per diluted shar

Aehr Test Systems (AEHR) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +1,200.00%. A quarter ago, it was expected that this company would post a loss of $0.08 per share when it actually produced a loss of $0.05, delivering a surprise of +37.5%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Aehr Test Systems, which belongs to the Zacks Electronics - Measuring Instruments industry, posted revenues of $18.84 million for the quarter ended May 2026, surpassing the Zacks Consensus Estimate by 0.72%. This compares to year-ago revenues of $14.09 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Aehr Test Systems shares have added about 236.9% since the beginning of the year versus the S&P 500's gain of 9.8%. While Aehr Test Systems has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Aehr Test Systems was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the com...

Aehr ended the quarter with an effective backlog of more than $100 million, providing strong visibility into future revenue. Fiscal 2027 revenue guidance of $130 million to $150 million is well above the $85.14 million analyst consensus, according to Fiscal.ai. Stocktwits retail sentiment turned ‘extremely bullish,’ with traders highlighting the raised FY2027 guidance and record backlog as key drivers. Shares of Aehr Test Systems (AEHR), a maker of semiconductor test and burn-in equipment, surged more than 40% in after-hours trading on Tuesday after the company reported better-than-expected earnings and revenue, along with record quarterly bookings of $60.7 million. It also issued a stronger-than-expected fiscal 2027 revenue outlook. At the time of writing, AEHR shares were up nearly 29% in after-hours trading after closing the regular session 5.87% higher. The stock was also among the top 10 trending tickers on Stocktwits. See what 10M+ investors are talking about. Get the Stocktwits Daily Rip for what retail is watching right now, free to your inbox For the fiscal fourth quarter ended in May, Aehr reported revenue of $18.84 million, up from $14.09 million a year earlier and above the $18.69 million consensus estimate, according to Fiscal.ai data. Non-GAAP net income rose to $3.6 million, or $0.11 per diluted share, from a non-GAAP net loss of $0.2 million, or $0.01 per diluted share, a year earlier. The company said its backlog stood at $80.6 million as of May 29, while its effective backlog, including bookings received after that date, increased to $100.6 million. Cash, cash equivalents, and restricted cash rose to $116.5 million from $37.1 million at the end of the previous quarter. Aehr also announced it has received more than $8 million in new silicon carbide wafer-level burn-in (WLBI) orders. These include a follow-on order for additional Fox WaferPak full wafer contactors from an existing silicon carbide production customer to support expanded manufacturing capacity for new electric vehicle platforms, particularly those serving the growing China EV market. Aehr expects fiscal 2027 revenue of $130 million to $150 million, well above the $85.14 million consensus estimate, according to Fiscal.ai. The company’s president and CEO Gayn Erickson, said Aehr entered fiscal 2027 with a record backlog of more than $100 million, providing substantial visibility...

Record quarterly bookings and effective backlog provide substantial visibility into projected fiscal 2027 revenue of $130 million to $150 million, representing 2.6x to 3.0x fiscal 2026 revenue FREMONT, CA / ACCESS Newswire / July 14, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced financial results for its fiscal 2026 fourth quarter and full year ended May 29, 2026. Fiscal Fourth Quarter Financial Results: Net revenue was $18.8 million, compared to $14.1 million in the fourth quarter of fiscal 2025. GAAP net income was $1.4 million, or $0.04 per diluted share, compared to GAAP net loss of $(2.9) million, or $(0.10) per diluted share, in the fourth quarter of fiscal 2025. Non-GAAP net income, which excludes stock-based compensation and acquisition-related adjustments, was $3.6 million, or $0.11 per diluted share, compared to non-GAAP net loss of $(0.2) million, or $(0.01) per diluted share, in the fourth quarter of fiscal 2025. Bookings were a record $60.7 million for the quarter. Backlog as of May 29, 2026 was $80.6 million. Effective backlog, including bookings since May 29, 2026, is $100.6 million. Total cash, cash equivalents and restricted cash as of May 29, 2026 was $116.5 million, compared to $37.1 million on February 27, 2026. Fiscal Year Financial Results: Net revenue was $50.0 million, compared to $59.0 million in fiscal 2025. GAAP net loss was $(7.1) million, or $(0.23) per diluted share, compared to GAAP net loss of $(3.9) million, or $(0.13) per diluted share, in fiscal 2025. Non-GAAP net income was $0.9 million, or $0.03 per diluted share, which excludes stock-based compensation, acquisition-related adjustments and restructuring charges, compared to non-GAAP net income of $4.6 million, or $0.15 per diluted share, in fiscal 2025. Cash used in operating activities was $3.3 million for fiscal 2026. An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr's non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables. Gayn Erickson, President and CEO of Aehr Test Systems, commented: "We are very pleased with our fiscal fourth quarter performance, which exceeded expecta...